Dr. Reddy's Laboratories Limited (DRREDDY) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Total Cash From Operating Activities Chart for Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited (DRREDDY) operating cash flow for FY2026 was INR 53.8B, a 16.0% change from FY2025. Dr. Reddy's Laboratories Limited's operating cash flow grew from INR 614.9M in 2001 to INR 53.8B in 2026 (8655.5% over 25 years). Operating cash flow compound annual growth rate: 5-year CAGR of 8.6%, 10-year CAGR of 2.7%, 20-year CAGR of 19.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.